Literature DB >> 5780532

The response of man to virulent Shigella flexneri 2a.

H L DuPont, R B Hornick, A T Dawkins, M J Snyder, S B Formal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5780532     DOI： 10.1093/infdis/119.3.296

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  41 in total

1.  Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

Authors:  David E Katz; Trinka S Coster; Marcia K Wolf; Fernando C Trespalacios; Dani Cohen; Guy Robins; Antoinette B Hartman; Malabi M Venkatesan; David N Taylor; Thomas L Hale
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 2.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

Review 3.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

Review 4.  The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.

Authors:  D J Philpott; J D Edgeworth; P J Sansonetti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

5.  Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.

Authors:  D Cohen; S Ashkenazi; M Green; Y Lerman; R Slepon; G Robin; N Orr; D N Taylor; J C Sadoff; C Chu; J Shiloach; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

6.  Human Intestinal Enteroids as a Model System of Shigella Pathogenesis.

Authors:  Benjamin J Koestler; Cara M Ward; C R Fisher; Anubama Rajan; Anthony W Maresso; Shelley M Payne
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

7.  Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a.

Authors:  G H Rabbani; M J Albert; H Rahman; M Islam; D Mahalanabis; I Kabir; K Alam; M Ansaruzzaman
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Fluid and electrolyte transport in rhesus monkeys challenged intracecally with Shigella flexneri 2a.

Authors:  M D Kinsey; S B Formal; G J Dammin; R A Giannella
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

9.  Establishment of a Shigella sonnei human challenge model in Thailand.

Authors:  Ladaporn Bodhidatta; Punnee Pitisuttithum; Supat Chamnanchanant; Karen T Chang; Dilara Islam; Valai Bussaratid; Malabi M Venkatesan; Thomas L Hale; Carl J Mason
Journal:  Vaccine       Date:  2012-10-12       Impact factor: 3.641

10.  Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants.

Authors:  Ryan T Ranallo; Robert W Kaminski; Tonia George; Alexis A Kordis; Qing Chen; Kathleen Szabo; Malabi M Venkatesan
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.